NJ biotech companies keep hiring; Lpath gets $3M grant;

 @FierceBiotech: NEJM lays out questions--and facts--about Provenge. Report | Follow @FierceBiotech

 @JohnCFierce: Genzyme breaks the $70 barrier on this morning's stories. Article | Follow @JohnCFierce

> The number of employees working at New Jersey biotechnology companies increased by 50 percent in the last three years, according to a survey conducted by BioNJ and Ernst & Young. Story

> Lpath was awarded a $3 million grant by the National Eye Institute's BRDG-SPAN Program to support Phase II clinical development of Lpath's iSONEP in treating exudative (or wet) AMD and possibly other ocular disorders. Lpath release

> B.C. should take Saskatchewan up on its invitation to help fund clinical trials of a controversial new treatment for multiple sclerosis, a provincial New Democrat says. News

> Singapore's position as a clinical research hub in the region is expected to be given a boost with the opening of a new clinical research unit. Report

> A London company may be on the verge of a groundbreaking treatment for diabetes--and an infusion of federal money announced yesterday in London may help it get there. Article

Special Report: Big Pharma's Q2 2010 Earnings Report. Report

And Finally... Hormonal contraceptives change the ways captive ring-tailed lemurs relate to one another both socially and sexually, according to a Duke University study that combined analyses of hormones, genes, scent chemicals and behavior. Report